BULLETIN V2026-1953
THIOGENESIS THERAPEUTICS, CORP. ("TTI")
BULLETIN TYPE: Private Placement-Non-Brokered
BULLETIN DATE: June 8, 2026
TSX Venture Tier 2 Company
Financing Type: Non-Brokered Private Placement
Gross Proceeds: $9,071,850.00
Offering: 18,143,700 Listed Shares
Offering Price: $0.50 per Listed Share
Commissions in Securities:
Shares
Warrants
Finders (Aggregate)
N/A
780,059
Commission Terms: Each non-transferable warrant is exercisable into a common share at $0.60 for a 3-year period
Disclosure: Refer to the company's news releases dated May 11, 2026, June 1, 2026 and June 3, 2026.
_______________________________________
|
|
